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Abstract
Background—Among heart failure (HF) patients, early readmission or death and repeat
hospitalizations may be indicators of poor disease management or more severe disease.
Methods and Results—We assessed the association of neighborhood median household
income (nINC) and Medicaid status with rehospitalization or death in the Atherosclerosis Risk in
Communities cohort study (1987–2004) following an incident HF hospitalization in the context of
individual socioeconomic status, and evaluated the relationship for modification by demographic
and comorbid factors. We used generalized linear Poisson mixed models to estimate
rehospitalization rate ratios and 95% confidence intervals (RR, 95% CI) and Cox regression to
estimate hazard ratios (HR, 95% CI) of rehospitalization or death. In models controlling for race/
study community, gender, age at HF diagnosis, body mass index, hypertension, educational
attainment, alcohol use and smoking, persons with a high burden of comorbidity who were living
in low nINC areas at baseline had an elevated hazard of all-cause rehospitalization (1.40, 1.10–
1.77), death (1.36, 1.02–1.80), and rehospitalization or death (1.36, 1.08–1.70)—as well as
increased rates of hospitalizations—compared to those with a high burden of comorbidity living in
high nINC areas. Medicaid recipients with a low level of comorbidity had an increased hazard of
all-cause rehospitalization (1.19, 1.05–1.36) and rehospitalization or death (1.21, 1.07–1.37), and a
higher rate of repeat hospitalizations compared to non-Medicaid recipients.
Conclusions—Comorbidity burden appears to influence the association between nINC,
Medicaid status and rehospitalization and death among HF patients.
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Hospital discharges for heart failure (HF) increased 157% from 1979 to 20021, and continue
to rise2. HF rehospitalizations, which are often preventable3, tend to be higher among older
patients, non-whites, and patients with prior hospitalizations and multiple primary care
visits4–6. In addition to being recognized as a major cause of serious morbidity7–9, HF
mortality is high10,11. From 1980 to 1995, the number of deaths in the US with an
underlying cause of HF increased nearly 70%12. HF is a primary or contributory cause of
more than 300,000 deaths each year in the US13, and HF mortality rates increase sharply
with age.
Among Atherosclerosis Risk in Communities (ARIC) study (1987–2002) cohort members
with incident HF, 30-day mortality was 10%, while one- and five-year mortality was 22%
and 42%, respectively14. Several studies with a combined endpoint of rehospitalization or
mortality report a prevalence of rehospitalization or death of 31–35% at 60 days15, and
81%16 at one year.
A shorter interval of time between initial hospitalization for HF and readmission or death
may be an indicator of more severe disease. Chronic conditions such as hypertension,
coronary heart disease (CHD), diabetes and obesity are risk factors for the development of
HF4, and clinical HF is commonly accompanied by one or more of these factors17. In
general, the burden of mortality10,18,19 and rehospitalization20 increases with increasing
comorbidity. However, in populations, variations in HF morbidity and mortality are not
completely explained by clinical features of the disease21, suggesting the need to explore
understudied domains, such as the influence of the socioeconomic context.
Low socioeconomic status is associated with higher HF incidence22–24, rehospitalization and
survival25–27. Meanwhile, health insurance status is associated with care-seeking behavior20
and subsequent disease outcomes28. Receipt of Medicaid, in particular, may exert effects on
health outcomes which are independent of socioeconomic status29,30, as coverage is
determined by having certain diseases and disabilities or an income below the poverty
line31. Evidence suggests that social and environmental contexts play an important role in
health outcomes32–34, however, research to date has not jointly assessed the effects of
neighborhood socioeconomic status and receipt of Medicaid on the risk of rehospitalization
or mortality among HF patients in the context of individual socioeconomic factors.
Furthermore, no published data are available which address whether the influence of the
socioeconomic context differs between patients with and without a high level of
comorbidity. We hypothesized that low neighborhood socioeconomic status and receipt of
Medicaid, respectively, would lead to earlier readmission or death, and that these factors
would impart a larger influence among participants with a higher burden of comorbidity.
Methods
ARIC cohort participants (N=15,792) were enrolled from 1987–1989 from the following
four US communities: Forsyth County, North Carolina; Washington County, Maryland;
suburbs of Minneapolis, Minnesota and Jackson, Mississippi35. As part of annual follow-up,
information regarding inpatient hospital stays is collected from cohort members, and
hospitalization data are abstracted from the medical record.
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All-cause hospitalizations are identified during annual follow-up or during routine ARIC
community surveillance36. For the current study, cardiovascular disease (CVD)-related
hospitalizations were further identified from all-cause hospitalizations using International
Classification of Diseases, Version 9 (ICD-9) discharge codes 402, 410–414, 427, 428, 430–
436 or 518.4; while a HF-related hospitalization was defined as that with an ICD-9
discharge code 42837.
Participants’ addresses obtained at baseline were assigned to the level of the census tract by
a vendor with high geocoding accuracy (Mapping Analytics)38. The 1990 US census tract-
level neighborhood-level socioeconomic measure selected for study was median household
income (nINC). In previous work, the use of the single-variable nINC measure produced
results of similar magnitude and precision when compared to a more complex composite
index measure of neighborhood SES39. We categorized nINC into community-wide tertiles
based upon participants’ place of residence at baseline, during the period 1987–1989: low (<
$24,777), medium ($24,777≤–<36,071) and high (≥$36,071).
After excluding 245 participants with prevalent HF at baseline, 1,415 participants had an
incident hospitalized HF event through 2004. An additional 70 participants were excluded
due to missing data on neighborhood socioeconomic status, and 3 were excluded due to
insufficient numbers for analysis because they were not white or black, or were blacks living
in Minnesota or Maryland, resulting in a final sample size of 1,342 participants.
Covariates included race/study community, gender, age at incident HF hospitalization and
selected socioeconomic, clinical and behavioral characteristics. Educational attainment was
assessed at baseline (less than 11 years, high school graduate, and greater than high school),
as was health insurance status at the time of the index HF hospitalization (receipt of
Medicaid, yes/no). Participants’ body mass index (BMI) was assessed at baseline and
classified as normal (<25 kg/m2), overweight (25–<30 kg/m2) or obese (≥30 kg/m2).
Hypertensive status at baseline was identified as systolic blood pressure ≥140 mmHg,
diastolic blood pressure ≥90 mmHg, or taking hypertensive medication within the previous
two weeks. Teaching status of the hospital during the index admission (teaching vs. non-
teaching), was based upon whether or not the hospital had an internal medicine residency
training program.
We ascertained the prevalence of common underlying conditions at the time of the index HF
hospitalization using ICD-9 discharge codes. The Charlson Index, a clinical comorbidity
algorithm19, was derived from these data. The Charlson Index is a validated measure used to
quantify the burden of comorbidity in several studies of mortality and adverse health
outcomes18,19. In its use with HF outcomes, a “modified” Charlson Index excludes chronic
HF from the conditions included in the computation of the comorbidity score40. Consistent
with previous studies, we defined a high burden of comorbidity as a sum of two or more
points on the Charlson Index scale, whereas a low burden of comorbidity was defined with a
total of zero to one points.
We used generalized linear Poisson mixed models to estimate all-cause, CVD-related and
HF-related rehospitalization rate ratios, comparing the rates of participants from low nINC
to high nINC, medium nINC to high nINC and Medicaid recipients to non-Medicaid
recipients, along with 95% confidence intervals (RR, 95% CI). This modelling strategy
accounted for repeat hospitalizations among patients as well as the clustering of patients
within census tracts. Time at risk for rehospitalization was the time elapsed between the
incident HF hospitalization admission date and death, loss to follow-up or the end of 2004,
whichever came first. We assessed for over-dispersion by consulting the deviance statistic of
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the Poisson model, and conducted supplementary analyses using negative binomial
regression when the deviance statistic exceeded one41.
The product-limit (Kaplan-Meier) method was used to measure time to readmission, death,
or readmission or death over the course of follow-up. Multivariate Cox proportional hazard
models estimated the risk of death or rehospitalization or death, and rehospitalization alone
using death during follow-up as the censoring variable. The model produced survival curves
depicting survival free of readmission or death, and the proportional hazards assumption was
assessed. All participants were censored at the end of 2004.
Crude nINC-rehospitalization/mortality analyses were conducted, the influence of covariates
in a full model were tested, and effect modification (pinteraction<0.05) of the nINC-
rehospitalization/mortality relationship was assessed by age, race/study community, gender,
hypertension, BMI and comorbidity index score. Analyses were performed by using SAS
Version 9.1 (SAS Institute, Inc., Cary, NC).
Results
Among participants with an incident HF hospitalization, 41% lived in low nINC, and one-
quarter resided in high nINC, areas at baseline. Approximately half (46%) were female, one-
third (33%) were black and the average age at the time of the index event was 67 years. As
shown in Table 1, a greater proportion (55%) of participants from low nINC areas had
attained 11 or fewer years of education, as compared to participants in medium (35%) and
high (19%) nINC areas. Twenty percent of participants living in low nINC areas were
Medicaid recipients, in contrast to 3% of those living in medium and high nINC areas (Table
2).
By the end of 2004, 89% of participants with an incident HF hospitalization had been
rehospitalized at least once (mean: 3.6; range: 0–47), 47% died, and 91% had been
rehospitalized or had died. Figure 1 shows life table trends of rehospitalization, death and
rehospitalization or death by person-time elapsed since the incident hospitalized HF event.
Of note, the cumulative proportion of persons experiencing rehospitalization or death is
quite similar to that of rehospitalization, but not death. At one year, 19% had died, 59% had
been rehospitalized, and 62% had been rehospitalized or had died (Figure 1).
Almost one-quarter of participants had a comorbidity index score of two or greater (Table
2). The most common comorbidities identified at the index hospitalization were chronic
pulmonary disease (27%), diabetes (22%) and myocardial infarction (13%). The
comorbidity index score modified the nINC-rehospitalization/mortality relationship (p<0.05)
in Cox proportional hazards (time-to-event) and Poisson (rate) analyses. Therefore,
subsequent results are presented stratified by level of the comorbidity score (≥2 vs. <2).
Time-to-event analyses
Crude median rehospitalization- and mortality-free survival times, in days, varied by
comorbidity index score (high vs. low) among participants in each nINC tertile [low nINC
(107 vs. 283), medium nINC (118 vs. 128) and high nINC (161 vs. 229)] as well as by
receipt of Medicaid [recipients (60 vs. 168), those not receiving Medicaid (133 vs. 217)].
Figure 2 shows rehospitalization-free survival curves, one for each level of comorbidity
burden, stratified by nINC. Among participants with a high burden of comorbidity, those
living in high nINC areas experienced the longest rehospitalization-free survival, while
those living in low nINC areas experienced the shortest. The observed nINC gradient did not
persist among participants with a low burden of comorbidity (Figure 2).
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The nINC/Medicaid-rehospitalization/mortality survival relationships (HR, 95% CI) are
shown in Table 3. In models controlling for race/study community, gender, age at HF
diagnosis, body mass index, hypertension, educational attainment, alcohol use and smoking,
persons with a high burden of comorbidity who were living in low nINC areas at baseline
had an elevated risk for all-cause rehospitalization (1.40, 1.10–1.77), death (1.36, 1.02–1.80)
and rehospitalization or death (1.36, 1.08–1.70) compared to those with a high burden of
comorbidity living in high nINC areas. In contrast, participants with a low burden of
comorbidity who were living in low nINC areas at baseline did not experience an increased
risk for death. Medicaid recipients with a low level of comorbidity had an increased risk of
all-cause rehospitalization (1.19, 1.05–1.36) and rehospitalization or death (1.21, 1.07–1.37)
compared to non-Medicaid recipients with a low level of comorbidity. Restricting the model
to include those in the lowest nINC tertile and combining across comorbidity categories, the
risk for all-cause rehospitalization among participants with Medicaid was 1.22 (1.07, 1.38)
compared to those without Medicaid. A significantly lower hazard of death was seen among
those with a higher burden of comorbidity living in medium nINC areas compared to those
living in high nINC areas (0.74, 0.59–0.93).
Rate analyses
Of 1,342 participants with an incident HF hospitalization, 148 (11%) were not rehospitalized
for any cause, while 318 (24%) were not rehospitalized for a CVD-related cause and 590
(44%) were not rehospitalized for HF. All-cause rehospitalization rates per 100 person-years
(95% CI) were 71.3 (63.3–80.4) for low nINC, 71.9 (64.5–80.2) for medium nINC, and 54.3
(47.7–61.7) for high nINC.
In models controlling for race/study community, gender, age at HF diagnosis, BMI,
hypertension, educational attainment, receipt of Medicaid, teaching hospital status, alcohol
use and smoking, participants with a higher burden of comorbidity living in low nINC areas
had a higher risk of all-cause (1.67, 1.01–2.76) and CVD-related (1.82, 1.08–3.07) – but did
not reach statistical significance for HF-related (1.65, 0.81–3.34) – hospitalizations,
compared to those with a high burden of comorbidity living in high nINC areas. Participants
living in medium nINC areas at baseline did not have an elevated risk compared to
participants living in high nINC areas, nor was there an nINC differential among
participants with a low burden of comorbidity. Similar results were seen for CVD-related
hospitalizations; however, no nINC effect in either strata of comorbidity burden was seen
for HF-related hospitalizations, possibly due to relatively few events meeting the criteria for
HF-related hospitalizations. Among participants with a low comorbidity burden, Medicaid
recipients were at increased risk for all-cause hospitalizations. The observed results persisted
for Medicaid recipients with a low comorbidity burden in analyses for CVD- and HF-related
hospitalizations (Figure 3).
In our data, the Poisson models used for estimating rehospitalization rate ratios yielded a
deviance statistic of close to four. Thus, over-dispersion was suggested. In response, we fit
negative binomial models to the data. As expected, the point estimates of the rate ratios did
not change, however, the confidence intervals widened with the application of the negative
binomial model, reflecting the effect over-dispersion had on these data. Although the
negative binomial estimates were less precise, the analyses accounting for over-dispersion
did not change our interpretation of the results.
Discussion
In this study, incident HF hospitalizations were more common among ARIC cohort
participants of low and medium nINC compared to those living in high nINC areas at
baseline. Further, low nINC participants with an elevated comorbidity index score at the
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time of the incident hospitalized HF event were rehospitalized at a higher rate than high
nINC participants in the same comorbidity category. These findings were consistent with a
review concluding that hospital admission rates increase with increased social deprivation42.
In addition, participants had an increased hazard of rehospitalization, death and
rehospitalization or death if they lived in a low nINC area at baseline and had a higher
burden of comorbidity, compared to participants living in high nINC areas at baseline with a
similar level of comorbidity.
Patients with limited neighborhood socioeconomic resources may not have adequate social
support or access to primary care facilities necessary to manage HF out-of-hospital. Persons
living in economically deprived areas may be less likely to have a primary care physician,
and thus may seek care in-hospital for conditions commonly managed out-of-hospital.
McAlister (2004) reported follow-up rates with primary care physicians were lowest among
patients with high neighborhood socioeconomic deprivation23. Fewer primary care visits
may be an indication of higher hospital utilization rates among patients of lower nINC. A
limitation of our study is that we are unable to take into account out-of-hospital management
of HF, as outpatient records were not available for the time period under study. Future
investigations in ARIC will, however, attempt to monitor the outpatient events related to
HF.
A related limitation of this study is the lack of information regarding HF medication
adherence post-discharge. To address this limitation, we assessed whether angiotensin-
converting enzyme inhibitors or beta-blockers were given during the hospitalization or at
discharge, and controlled for these factors in models containing all potential confounders.
Inclusion of the HF medication variables did not appreciably change the estimates (<5%)
and did not alter our interpretation of the results.
Medicaid recipients without a high burden of comorbidity tended to have a higher hazard of
first rehospitalization, and were rehospitalized more often than participants not receiving
Medicaid. It is possible that the Medicaid recipients in this study with greater comorbidity
were more likely to seek or be referred to care for symptom managment out-of-hospital and
as a result did not require more frequent hospitalizations than non-Medicaid recipients with
a high comorbidity burden. Conversely, the Medicaid recipients with fewer comorbidities in
this study may not have been as aggressively managed in- or out-of- hospital, leading to a
higher hazard of first rehospitalization following the index HF hospitalization. However,
these estimates should be interpreted with caution, as the number of Medicaid recipients
with a high comorbidity burden in these data was relatively small.
Shorter median times from the index event to readmission among those living in low nINC
areas appeared to be a strong influence on the combined rehospitalization/mortality
endpoint, as low nINC was not a predictor for HF survival across levels of comorbidity in
the ARIC study population. In particular, rehospitalization occurs more often and more
quickly among participants living in low nINC areas, especially among those with more
comorbidities identified during the incident hospitalized event. In general, patients with
more comorbidity may require a greater number of treatments because they are sicker, more
susceptible to severe HF, or experience acute exacerbations of the disease. Requiring more
medical attention due to a high burden of comorbidity may serve to highlight the limited
resources available in low nINC areas, either for adequate self-care43 or out-of-hospital
management of disease.
A strength of this study is its inclusion of a racially diverse population of men and women
who were free of HF at baseline and followed from 1987 to 2004 in order to capture an
incident HF hospitalization, subsequent hospitalizations and fatal events. Longer follow-up
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more adequately depicts the survival experience and clinical course of HF progression for
the majority of HF patients. Blacks living in Jackson, Mississippi constituted the majority of
HF patients who both resided in low nINC areas at baseline and were Medicaid recipients.
This limitation highlights the difficulty of disentangling race and socioeconomic
disadvantage in our society.
The index HF hospitalization was defined as the first mention of a 428 ICD-9 discharge
code in the medical record, a technique used in extant studies of HF14. We acknowledge
limitations inherent to this method of event identification, such as an inability to distinguish
between acute and chronic HF events as well as not being able to determine the etiology of
the incident hospitalized event. Although the identification of incident events via ICD-9
discharge codes does not capture outpatient events that may have occurred prior the incident
hospitalized event, the distribution of hospitalizations among ARIC participants with
incident hospitalized HF were similar to a recently published community-based report which
ascertained incident HF cases from both outpatient and inpatient records44.
In the context of increasing hospital discharges for HF and a consistently high rate of
mortality from the syndrome, it is critical to identify social and economic neighborhood
forces which impact HF rehospitalization or death in the presence of individual
socioeconomic, demographic and comorbid factors. Differences by nINC in survival free
from readmission or death post-incident HF hospitalization may have important implications
for the management and treatment of HF patients45,46. It is likely that nINC in part
determines the availability of health care resources in a community, such as the proximity of
neighborhood health clinics. Outpatient care is critical to the out-of-hospital monitoring of
HF patients, and if less available in low nINC areas, may adversely affect the progression of
HF among patients in these communities47. In this study, Medicaid recipients with a low
burden of comorbidity were more likely to be admitted to the hospital following an incident
hospitalized HF event. Whether these patients are adequately monitored on an outpatient
basis remains unclear. Regardless, comorbidity burden appears to modify the association
between nINC, Medicaid status and rehospitalization and death among HF patients.
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Cumulative proportion of participants with an incident heart failure hospitalization
experiencing rehospitalization, death and rehospitalization or death, The ARIC study (1987–
2004)
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Survival after the Incident HF Hospitalization: Time to Rehospitalization by Comorbidity
Burden and nINC: The ARIC study (1987–2004).
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Rate Ratios (and 95% CI) for All-cause, CVD- and HF-related Rehospitalizations among
Participants with Incident Hospitalized HF: The ARIC study (1987–2004).
*nINC and Medicaid status plus race/study community, gender and age at index event
†Model 1 plus hypertension, body mass index, current smoker, current drinker and
educational attainment
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Table 3
Hazard Ratios (HR) and 95% Confidence Intervals (95% CI) for all-cause rehospitalization, death, and
rehospitalization or death following an Incident Hospitalized Heart Failure Event by nINC, Stratified by
Charlson Index Score: The ARIC study, 1987–2004.
Charlson Index Score ≥2 Charlson Index Score <2
Model 1* Model 2† Model 1* Model 2†
All-cause Rehospitalization
nINC
 Low 1.23 (1.00, 1.51) 1.40 (1.10, 1.77) 1.13 (1.01, 1.26) 1.16 (1.04, 1.30)
 Medium 1.07 (0.91, 1.27) 1.14 (0.95, 1.36) 1.26 (1.15, 1.39) 1.28 (1.16, 1.41)
 High 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent)
Medicaid Recipient
 Yes 1.18 (0.95, 1.46) 1.12 (0.89, 1.40) 1.17 (1.03, 1.32) 1.19 (1.05, 1.36)
 No 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent)
  Death
nINC
 Low 1.34 (1.04, 1.72) 1.36 (1.02, 1.80) 1.12 (0.97, 1.30) 1.09 (0.94, 1.26)
 Medium 0.75 (0.61, 0.93) 0.74 (0.59, 0.93) 0.91 (0.79, 1.03) 0.90 (0.78, 1.02)
 High 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent)
Medicaid Recipient
 Yes 0.99 (0.76, 1.30) 0.95 (0.72, 1.25) 1.03 (0.87, 1.23) 0.96 (0.80, 1.14)
 No 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent)
All-cause Rehospitalization or Death
nINC
 Low 1.23 (1.01, 1.50) 1.36 (1.08, 1.70) 1.09 (0.98, 1.21) 1.13 (1.02, 1.26)
 Medium 1.00 (0.85, 1.17) 1.04 (0.87, 1.23) 1.24 (1.13, 1.36) 1.27 (1.15, 1.39)
 High 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent)
Medicaid Recipient
 Yes 1.23 (1.00, 1.51) 1.17 (0.95, 1.45) 1.17 (1.04, 1.32) 1.21 (1.07, 1.37)
 No 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent)
*
nINC and Medicaid status plus race/study community, gender and age at index event
†
Model 1 plus hypertension, body mass index, current smoker, current drinker and educational attainment
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